Umeå University's logo

umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The Abbey Pain Scale: not sufficiently valid or reliable for assessing pain in patients with advanced cancer
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.ORCID-id: 0000-0002-0125-629X
Umeå universitet, Medicinska fakulteten, Institutionen för omvårdnad.ORCID-id: 0000-0002-1248-5581
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.ORCID-id: 0000-0003-4126-2675
2023 (engelsk)Inngår i: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 62, nr 8, s. 953-960Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Background: Patients with advanced cancer can be unable to verbalize their pain. The Abbey Pain Scale (APS), an observational tool, is used to assess pain in this setting, but has never been psychometrically tested for people with cancer. The aim of this study was to assess the validity, reliability, and the responsiveness of the APS to opioids for patients with advanced cancer in a palliative oncology care setting.

Material and Methods: Patients with advanced cancer and poor performance status, drowsiness, unconsciousness, or delirium, were assessed for pain using a Swedish translation of the APS (APS-SE) and, if possible, the Numeric Rating Scale (NRS). The assessments using APS were conducted simultaneously, but independently, by the same raters on two separate occasions, approximately one hour apart. Criterion validity was assessed by comparing the APS and NRS values using Cohen’s kappa (κ). Inter-rater reliability was determined using the intraclass correlation coefficient (ICC), internal consistency using Cronbach’s α, and responsiveness to opioids using the Wilcoxon signed-rank test.

Results: Seventy-two patients were included, of whom n = 45 could rate their pain using the NRS. The APS did not detect any of the n = 22 cases of moderate or severe pain self-reported using the NRS. The APS at first assessment had a κ of 0.08 (CI: −0.06 to 0.22) for criterion validity, an ICC of 0.64 (CI: 0.43–0.78) for inter-rater reliability, and a Cronbach’s α of 0.01 for internal consistency. The responsiveness to opioids was z = −2.53 (p = 0.01).

Conclusion: The APS was responsive to opioids but displayed insufficient validity and reliability and did not detect moderate or severe pain as indicated by the NRS. The study showed a very limited clinical use of the APS in patients with advanced cancer.

sted, utgiver, år, opplag, sider
Taylor & Francis, 2023. Vol. 62, nr 8, s. 953-960
Emneord [en]
Abbey Pain Scale, cancer, Pain assessment, reliability, responsiveness, validity
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-212109DOI: 10.1080/0284186X.2023.2228992ISI: 001019893100001PubMedID: 37382384Scopus ID: 2-s2.0-85163716000OAI: oai:DiVA.org:umu-212109DiVA, id: diva2:1782765
Forskningsfinansiär
Cancerforskningsfonden i Norrland, 18-922Västerbotten County Council, 7003533Tilgjengelig fra: 2023-07-17 Laget: 2023-07-17 Sist oppdatert: 2025-02-11bibliografisk kontrollert
Inngår i avhandling
1. Pain or no pain? That is the question: an evaluation of the observational pain assessment instrument Abbey Pain Scale in patients with cancer
Åpne denne publikasjonen i ny fane eller vindu >>Pain or no pain? That is the question: an evaluation of the observational pain assessment instrument Abbey Pain Scale in patients with cancer
2024 (engelsk)Doktoravhandling, med artikler (Annet vitenskapelig)
Alternativ tittel[sv]
Smärta eller inte smärta? Det är frågan : en utvärdering av observationssmärtskattningsskalan Abbey Pain Scale vid användning hos patienter med cancer
Abstract [en]

Background: The Abbey Pain Scale (APS) is an observational pain assessment instrument that was created for use among patients with dementia. It is sometimes used in Sweden to assess pain in patients with advanced cancer who are unable to vocalize their pain, but it has never been evaluated in this population.

Aim: To evaluate observational pain assessment for people with advanced cancer in a palliative care setting, focusing on the APS.

Methods: The APS was translated and adapted into a Swedish dementia context through interviews with health care professionals (n=11). The resulting APS-SE was then used in a qualitative content analysis exploring health care professionals’ experience of using the instrument in patients with advanced cancer (n=12). The psychometrics of the APS-SE when used in patients with advanced cancer (n=72) were determined through test-retest and inter-rater reliability, internal consistency reliability, and responsiveness to opioids. Criterion validity was determined against the patients’ self-reported pain (n=45).

Results: The APS-SE was comprehensible by users within dementia care, regardless of their educational and linguistic background. The qualitative analysis revealed that when used in patients with advanced cancer, the APS-SE fulfilled the need for an observational pain assessment instrument, but was not always on target and did not fully suit the clinical situation. The psychometric analysis showed slight criterion validity (κ=0.08) and unacceptable internal consistency reliability (Cronbach’s α=0.01). The test-retest reliability was good (ICC=0.82) and the inter-rater reliability moderate (ICC=0.64), but the latter had a confidence interval ranging from poor to good. Responsiveness to opioids was demonstrated (p=0.01).

Conclusions: This thesis underscores the need for a specialized observational pain assessment instrument explicitly tailored for patients with advanced cancer. The current lack of a recognized alternative emphasizes the importance of developing such an instrument to address the critical gap in observational pain assessment in the palliative oncology setting.

sted, utgiver, år, opplag, sider
Umeå: Umeå University, 2024. s. 95
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 2296
Emneord
Abbey Pain Scale, APS-SE, cancer pain, observational pain assessment, advanced cancer, end-of-life care, palliative oncology
HSV kategori
Forskningsprogram
onkologi
Identifikatorer
urn:nbn:se:umu:diva-223902 (URN)9789180703482 (ISBN)9789180703499 (ISBN)
Disputas
2024-06-05, Bergasalen, Norrlands universitetssjukhus, Umeå, 09:00 (svensk)
Opponent
Veileder
Tilgjengelig fra: 2024-05-13 Laget: 2024-04-30 Sist oppdatert: 2024-05-06bibliografisk kontrollert

Open Access i DiVA

fulltext(1157 kB)822 nedlastinger
Filinformasjon
Fil FULLTEXT02.pdfFilstørrelse 1157 kBChecksum SHA-512
b9c3389c809e873b4659daf88956442ce78a42afdcb4c8bd7b4c591445bd157db449c5c2a0f5f4c2f1673780235eb25d3a2bcbe9d666962e2d5ded71ed74ae9e
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Tegenborg, SussiFransson, PerMartinsson, Lisa

Søk i DiVA

Av forfatter/redaktør
Tegenborg, SussiFransson, PerMartinsson, Lisa
Av organisasjonen
I samme tidsskrift
Acta Oncologica

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 927 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 1168 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf